Treat chronic nerve pain with a much smaller implant and simpler surgery by moving the battery outside the body, so it never needs a replacement operation.
Part of Boston Scientific since Jan 2026; sales over $60M in 2025, expected to grow 25%+ in 2026.
Updated 27 Jan 2026Checked 11 Oct0 updates this week
The implanted pulse generator has no battery, so it can be far smaller than a normal stimulator and placed near the painful area.
A Therapy Disc worn on the skin holds the battery and beams energy through the skin to run the implant while it is worn.
Leads deliver mild electrical pulses to a peripheral nerve, interrupting its pain signals before they reach the spinal cord and brain.
Patients adjust stimulation from a smartphone app, and the software can be updated over time.
| Spec | Nalu Neurostimulation System |
|---|---|
| COMFORT: >50% pain relief at 12 months | 87% of patientsR (reported) |
| COMFORT 2: responders at 6 months | 79%, avg 64% reliefR (reported) |
| Real-world meaningful improvement | 94% of 2,000+ patientsR (reported) |
| 2025 sales (expected) | >$60MR (reported) |
| Acquisition value (100% basis) | $600MR (reported) |
R reported by the company
Boston Scientific
Neuromodulation, DBS, cardiovascular devices, medical devices
Boston Scientific manufactures DBS systems including Vercise Genus with 16-contact directional leads. Entered neuromodulation via Advanced Bionics (2004) and Intelect Medical (2011).
bostonscientific.com (opens bostonscientific.com)Company profile →
